» Articles » PMID: 31861527

Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other...

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2019 Dec 22
PMID 31861527
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The systematic review of the marine pharmacology literature from 2014 to 2015 was completed in a manner consistent with the 1998-2013 reviews of this series. Research in marine pharmacology during 2014-2015, which was reported by investigators in 43 countries, described novel findings on the preclinical pharmacology of 301 marine compounds. These observations included antibacterial, antifungal, antiprotozoal, antituberculosis, antiviral, and anthelmintic pharmacological activities for 133 marine natural products, 85 marine compounds with antidiabetic, and anti-inflammatory activities, as well as those that affected the immune and nervous system, and 83 marine compounds that displayed miscellaneous mechanisms of action, and may probably contribute to novel pharmacological classes upon further research. Thus, in 2014-2015, the marine natural product pharmacology pipeline provided novel pharmacology as well as new lead compounds for the marine pharmaceutical pipeline, and thus continued to contribute to ongoing global research for alternative therapeutic approaches to many disease categories.

Citing Articles

The Marine Fish Gut Microbiome as a Source of Novel Bacteriocins.

Uniacke-Lowe S, Stanton C, Hill C, Ross R Microorganisms. 2024; 12(7).

PMID: 39065114 PMC: 11278639. DOI: 10.3390/microorganisms12071346.


Marine Pharmacology in 2019-2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous....

Mayer A, Mayer V, Swanson-Mungerson M, Pierce M, Rodriguez A, Nakamura F Mar Drugs. 2024; 22(7).

PMID: 39057418 PMC: 11278370. DOI: 10.3390/md22070309.


Antibacterial properties of natural products from marine fungi reported between 2012 and 2023: a review.

Wang P, Huang X, Jiang C, Yang R, Wu J, Liu Y Arch Pharm Res. 2024; 47(6):505-537.

PMID: 38850495 DOI: 10.1007/s12272-024-01500-6.


Bioactive compounds and biomedical applications of endophytic fungi: a recent review.

Hashem A, Attia M, Kandil E, Fawzi M, Abdelrahman A, Khader M Microb Cell Fact. 2023; 22(1):107.

PMID: 37280587 PMC: 10243280. DOI: 10.1186/s12934-023-02118-x.


Marine Compounds and Cancer: Updates 2022.

Dyshlovoy S, Honecker F Mar Drugs. 2022; 20(12).

PMID: 36547906 PMC: 9783002. DOI: 10.3390/md20120759.


References
1.
Gros E, Al-Mourabit A, Martin M, Sorres J, Vacelet J, Frederich M . Netamines H-N, tricyclic alkaloids from the marine sponge Biemna laboutei and their antimalarial activity. J Nat Prod. 2014; 77(4):818-23. DOI: 10.1021/np4009283. View

2.
Su Y, Su T, Wen Z, Hwang T, Fang L, Chen J . Briarenolides K and L, new anti-inflammatory briarane diterpenoids from an octocoral Briareum sp. (Briareidae). Mar Drugs. 2015; 13(2):1037-50. PMC: 4344617. DOI: 10.3390/md13021037. View

3.
DeGroot D, Franks D, Higa T, Tanaka J, Hahn M, Denison M . Naturally occurring marine brominated indoles are aryl hydrocarbon receptor ligands/agonists. Chem Res Toxicol. 2015; 28(6):1176-85. PMC: 4469569. DOI: 10.1021/acs.chemrestox.5b00003. View

4.
Jiao W, Li J, Liu Q, Xu T, Shi G, Yu H . Dysidinoid A, an unusual meroterpenoid with anti-MRSA activity from the South China Sea sponge Dysidea sp. Molecules. 2014; 19(11):18025-32. PMC: 6270960. DOI: 10.3390/molecules191118025. View

5.
Bae M, Kim H, Moon K, Nam S, Shin J, Oh K . Mohangamides A and B, new dilactone-tethered pseudo-dimeric peptides inhibiting Candida albicans isocitrate lyase. Org Lett. 2015; 17(3):712-5. DOI: 10.1021/ol5037248. View